Systems Engineer at Clairo

San Pedro Garza García, Nuevo Leon, Mexico

Apply Now

Not SpecifiedCompensation

Mid-level (3 to 4 years), Senior (5 to 8 years)Experience Level

Full TimeJob Type

UnknownVisa

Automotive, Battery TechnologyIndustries

Requirements

Strong background in battery technology, automotive systems engineering, and compliance with industry standards (ASPICE, ISO 26262, ISO 15288, INCOSE SE Handbook)
Experience with Li-Ion and/or ultra-capacitor battery systems for low-voltage (12V-48V) automotive applications
Proficiency in requirements management tools for traceability between system requirements, architecture, and validation plans

Responsibilities

Capture, analyze, and refine system-level requirements from OEMs, product management, and internal teams; allocate performance and limiting requirements to functional levels; ensure traceability and balance competing requirements
Define system architectures, including cell selection, thermal, electrical, and mechanical interfaces; develop block diagrams, interface definitions, and schematics; allocate requirements to subsystems and manage trade-offs
Implement functional safety according to Clarios Functional Safety Process (ISO 26262), including HARA, FTA, FMEA, Common-Mode Analysis; own system-level DFMEA and coordinate with subsystem/component FMEAs; define safety goals and validation strategies
Define and manage thermal, electrical, and mechanical interfaces between battery pack, BMS, ultra-capacitor system, and vehicle powertrain; collaborate with software, mechanical, and electrical teams for optimization; support HiL and MiL testing
Lead development of Design Verification Plans (DVPs); ensure verification coverage with traceability; participate in system-level validation, durability testing, failure mode analysis, aging studies, thermal modeling, and electrical load analysis
Ensure designs are optimized for manufacturability (DFM), assembly, and scalability; collaborate with manufacturing, quality, and supply chain teams; support APQP, control plans, and DFMEA; release designs to production
Own system-level DFMEA and ensure alignment with subsystem/component DFMEAs; align with ASPICE 3.1, ISO 15288, and INCOSE best practices
Act as technical liaison for cross-functional collaboration and leadership

Skills

Li-Ion Batteries

Ultra-Capacitors

Systems Engineering

Requirements Engineering

System Architecture

Functional Safety

ISO 26262

ASPICE

ISO 15288

HARA

FTA

FMEA

DFMEA

Automotive Systems

Clairo

Generates clinical evidence for trials

About Clairo

Clario specializes in generating clinical evidence for medical research by utilizing a comprehensive technology platform. Their services support various types of clinical trials, including decentralized, hybrid, and site-based trials. Clario's approach combines nearly 50 years of experience with a vast network of facilities across nine countries, allowing them to conduct a significant number of clinical trials and regulatory approvals. What sets Clario apart from competitors is their extensive expertise and the ability to provide a wide range of endpoint technologies, which enhances the quality of evidence produced. The company's goal is to empower partners in the healthcare industry to improve patient outcomes through reliable and rich clinical data.

London, United KingdomHeadquarters

1972Year Founded

$29.9MTotal Funding

GROWTH_EQUITY_VCCompany Stage

Biotechnology, HealthcareIndustries

5,001-10,000Employees

Benefits

Competitive and equitable total rewards package

Physical, mental and financial health and wellness

Flexible working approach

Risks

Increased competition from AI-driven platforms like Medable may threaten Clario's market share.

The IPO filing may lead to investor pressure for rapid financial returns, affecting strategy.

AI integration from ArtiQ poses data privacy and compliance risks, especially in the EU.

Differentiation

Clario offers a comprehensive endpoint technology platform for diverse clinical trial models.

The company has nearly 50 years of experience in clinical trial technology solutions.

Clario's global presence includes 30 facilities across North America, Europe, and Asia Pacific.

Upsides

Clario's IPO aims for a valuation of over $10 billion, indicating strong market confidence.

The FDA clearance of SpiroSphere® with wireless ECG enhances Clario's clinical trial capabilities.

Clario's acquisition of ArtiQ boosts its AI capabilities in respiratory clinical trials.

Land your dream remote job 3x faster with AI

Try Jobo Free